{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:08:21Z","timestamp":1789081701633,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":93,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Chongqing Traditional Chinese Medicine Innovation Team: \"Innovative Team for the Development of New Targeted Delivery Traditional Chinese Medicine Formulations.\""},{"name":"Chongqing medical scientific research project","award":["2025ZDXM036"],"award-info":[{"award-number":["2025ZDXM036"]}]},{"name":"Project of Chongqing Natural Science Foundation","award":["CSTB2024NSCQ-MSX0270"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0270"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04640-7","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:54:39Z","timestamp":1781070879000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual metabolic intervention nanoplatform co-delivering BAY-876 and L-cystine for Wilms tumor therapy via disulfidptosis-associated cytoskeletal collapse"],"prefix":"10.1186","volume":"24","author":[{"given":"Junyi","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinkui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YongLin","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohai","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"4640_CR1","doi-asserted-by":"publisher","unstructured":"Neagu MC, David VL, Iacob ER, Chiriac SD, Muntean FL, Boia ES. Wilms\u2019 Tumor: A Review of Clinical Characteristics, Treatment Advances, and Research Opportunities. Med (Kaunas). 2025;61(3). https:\/\/doi.org\/10.3390\/medicina61030491.","DOI":"10.3390\/medicina61030491"},{"issue":"1","key":"4640_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3978\/j.issn.2224-4336.2014.01.09","volume":"3","author":"E Szychot","year":"2014","unstructured":"Szychot E, Apps J, Pritchard-Jones K. Wilms\u2019 tumor: biology, diagnosis and treatment. Transl Pediatr. 2014;3(1):12\u201324. https:\/\/doi.org\/10.3978\/j.issn.2224-4336.2014.01.09.","journal-title":"Transl Pediatr"},{"issue":"1","key":"4640_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jpurol.2008.08.007","volume":"5","author":"EY Ko","year":"2009","unstructured":"Ko EY, Ritchey ML. Current management of Wilms\u2019 tumor in children. J Pediatr Urol. 2009;5(1):56\u201365. https:\/\/doi.org\/10.1016\/j.jpurol.2008.08.007.","journal-title":"J Pediatr Urol"},{"issue":"36","key":"4640_CR4","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1200\/jco-25-00532","volume":"43","author":"DB Dix","year":"2025","unstructured":"Dix DB, Khanna G, Renfro LA, Tfirn IC, Smith EA, Artunduaga M, Eklund MJ, Sandberg JK, Parsons LN, Kalapurakal JA, Ehrlich PF, Aldrink JH, Glick RD, Benedetti DJ, Fernandez CV, Dome JS, Mullen EA, Geller JI. Impact of Pulmonary Tumor Burden in Favorable Histology Wilms Tumor Outcomes: A Report From the Children\u2019s Oncology Group Study AREN0533. J Clin Oncol. 2025;43(36):3822\u201332. https:\/\/doi.org\/10.1200\/jco-25-00532.","journal-title":"J Clin Oncol"},{"issue":"14","key":"4640_CR5","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1158\/1078-0432.Ccr-23-0311","volume":"29","author":"B Rastegar","year":"2023","unstructured":"Rastegar B, Andersson N, Petersson A, Karlsson J, Chattopadhyay S, Valind A, Jansson C, Durand G, Romerius P, Jirstr\u00f6m K, Holmquist Mengelbier L, Gisselsson D. Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution. Clin Cancer Res. 2023;29(14):2668\u201377. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-23-0311.","journal-title":"Clin Cancer Res"},{"key":"4640_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2022.01.036","volume":"166","author":"W Mifsud","year":"2022","unstructured":"Mifsud W, Furtw\u00e4ngler R, Vokuhl C, D\u2019Hooghe E, Pritchard-Jones K, Graf N, Vujani\u0107 GM. Treatment of patients with stage I focal anaplastic and diffuse anaplastic Wilms tumour: A report from the SIOP-WT-2001 GPOH and UK-CCLG studies. Eur J Cancer. 2022;166:1\u20137. https:\/\/doi.org\/10.1016\/j.ejca.2022.01.036.","journal-title":"Eur J Cancer"},{"issue":"2","key":"4640_CR7","doi-asserted-by":"publisher","first-page":"e35713","DOI":"10.1002\/cncr.35713","volume":"131","author":"AE Armstrong","year":"2025","unstructured":"Armstrong AE, Daw NC, Renfro LA, Geller JI, Kalapurakal JA, Khanna G, Paulino AC, Perlman EJ, Ehrlich PF, Gow KW, Warwick AB, Grundy PE, Fernandez CV, Mullen EA, Dome JS. Treatment of focal anaplastic Wilms tumor: A report from the Children\u2019s Oncology Group AREN0321 and AREN03B2 studies. Cancer. 2025;131(2):e35713. https:\/\/doi.org\/10.1002\/cncr.35713.","journal-title":"Cancer"},{"issue":"6","key":"4640_CR8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/ijc.34006","volume":"151","author":"MEM van der Perk","year":"2022","unstructured":"van der Perk MEM, Cost NG, Bos AME, Brannigan R, Chowdhury T, Davidoff AM, Daw NC, Dome JS, Ehrlich P, Graf N, Geller J, Kalapurakal J, Kieran K, Malek M, McAleer MF, Mullen E, Pater L, Polanco A, Romao R, Saltzman AF, Walz AL, Woods AD, van den Heuvel-Eibrink MM. Fernandez, White paper: Oncofertility in pediatric patients with Wilms tumor. Int J Cancer. 2022;151(6):843\u201358. https:\/\/doi.org\/10.1002\/ijc.34006.","journal-title":"Int J Cancer"},{"key":"4640_CR9","doi-asserted-by":"publisher","first-page":"156659","DOI":"10.1016\/j.phymed.2025.156659","volume":"141","author":"DH Wang","year":"2025","unstructured":"Wang DH, Ma XN, Wang Y, Wei YX, Hu P, Pan Y. Validated herbal extracts for alleviating chemotherapy-induced myelosuppression: A systematic review and meta-analysis. Phytomedicine. 2025;141:156659. https:\/\/doi.org\/10.1016\/j.phymed.2025.156659.","journal-title":"Phytomedicine"},{"issue":"1","key":"4640_CR10","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1038\/s41467-025-60015-w","volume":"16","author":"W Yu","year":"2025","unstructured":"Yu W, Jin D, Zhang Y, Wang S, Yu J, Liu M, Dai Y, Yin Y, Cheng J, Liu Y. Provoking tumor disulfidptosis by single-atom nanozyme via regulating cellular energy supply and reducing power. Nat Commun. 2025;16(1):4877. https:\/\/doi.org\/10.1038\/s41467-025-60015-w.","journal-title":"Nat Commun"},{"issue":"11","key":"4640_CR11","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1002\/mco2.791","volume":"5","author":"T Mi","year":"2020","unstructured":"Mi T, Kong X, Chen M, Guo P, He D. Inducing disulfidptosis in tumors:potential pathways and significance. MedComm. 2020;5(11):2024\u2013e791. https:\/\/doi.org\/10.1002\/mco2.791.","journal-title":"MedComm"},{"issue":"1","key":"4640_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s11658-025-00743-5","volume":"30","author":"Y Liu","year":"2025","unstructured":"Liu Y, Li S, Wu Y, Zhang P, Yu Y, Chen X, Yu L, Yang X, Li H, Wu C, Du J, Li Y. Molecular signatures of disulfidptosis: interplay with programmed cell death pathways and therapeutic implications in oncology. Cell Mol Biol Lett. 2025;30(1):66. https:\/\/doi.org\/10.1186\/s11658-025-00743-5.","journal-title":"Cell Mol Biol Lett"},{"issue":"23","key":"4640_CR13","doi-asserted-by":"publisher","first-page":"e2500880","DOI":"10.1002\/smll.202500880","volume":"21","author":"W Zhen","year":"2025","unstructured":"Zhen W, Zhao T, Chen X, Zhang J. Unlocking the Potential of Disulfidptosis: Nanotechnology-Driven Strategies for Advanced Cancer Therapy. Small. 2025;21(23):e2500880. https:\/\/doi.org\/10.1002\/smll.202500880.","journal-title":"Small"},{"issue":"4","key":"4640_CR14","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41418-024-01440-0","volume":"32","author":"M Tang","year":"2025","unstructured":"Tang M, Dirks K, Kim SY, Qiu Z, Gao Y, Sun D, Peruggia G, Sallavanti J, Li W. Inhibition of thioredoxin reductase 1 sensitizes glucose-starved glioblastoma cells to disulfidptosis. Cell Death Differ. 2025;32(4):598\u2013612. https:\/\/doi.org\/10.1038\/s41418-024-01440-0.","journal-title":"Cell Death Differ"},{"key":"4640_CR15","doi-asserted-by":"publisher","first-page":"115094","DOI":"10.1016\/j.colsurfb.2025.115094","volume":"257","author":"Z Ye","year":"2026","unstructured":"Ye Z, Yao Y, Xu Y, Ye J, Yao Q, Kou L, Chen R. Nanomedicine strategies for disulfidptosis activation in SLC7A11-high tumors. Colloids Surf B Biointerfaces. 2026;257:115094. https:\/\/doi.org\/10.1016\/j.colsurfb.2025.115094.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1","key":"4640_CR16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1186\/s12964-024-01871-9","volume":"22","author":"T Li","year":"2024","unstructured":"Li T, Song Y, Wei L, Song X, Duan R. Disulfidptosis: a novel cell death modality induced by actin cytoskeleton collapse and a promising target for cancer therapeutics. Cell Commun Signal. 2024;22(1):491. https:\/\/doi.org\/10.1186\/s12964-024-01871-9.","journal-title":"Cell Commun Signal"},{"issue":"3","key":"4640_CR17","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.7150\/ijbs.90606","volume":"20","author":"X Wang","year":"2024","unstructured":"Wang X, Zheng C, Yao H, Guo Y, Wang Y, He G, Fu S, Deng X. Disulfidptosis: Six Riddles Necessitating Solutions. Int J Biol Sci. 2024;20(3):1042\u20134. https:\/\/doi.org\/10.7150\/ijbs.90606.","journal-title":"Int J Biol Sci"},{"issue":"8","key":"4640_CR18","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12(8):599\u2013620. https:\/\/doi.org\/10.1007\/s13238-020-00789-5.","journal-title":"Protein Cell"},{"issue":"3","key":"4640_CR19","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","volume":"25","author":"X Liu","year":"2023","unstructured":"Liu X, Nie L, Zhang Y, Yan Y, Wang C, Colic M, Olszewski K, Horbath A, Chen X, Lei G, Mao C, Wu S, Zhuang L, Poyurovsky MV, James You M, Hart T, Billadeau DD, Chen J, Gan B. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat Cell Biol. 2023;25(3):404\u201314. https:\/\/doi.org\/10.1038\/s41556-023-01091-2.","journal-title":"Nat Cell Biol"},{"key":"4640_CR20","doi-asserted-by":"publisher","unstructured":"Aurora AB, Khivansara V, Leach A, Gill JG, Martin-Sandoval M, Yang C, Kasitinon SY, Bezwada D, Tasdogan A, Gu W, Mathews TP, Zhao Z, DeBerardinis RJ, Morrison SJ. Loss of glucose 6-phosphate dehydrogenase function increases oxidative stress and glutaminolysis in metastasizing melanoma cells. Proc Natl Acad Sci U S A. 2022;119(6). https:\/\/doi.org\/10.1073\/pnas.2120617119.","DOI":"10.1073\/pnas.2120617119"},{"issue":"1","key":"4640_CR21","doi-asserted-by":"publisher","first-page":"110607","DOI":"10.1016\/j.celrep.2022.110607","volume":"39","author":"C Chen","year":"2022","unstructured":"Chen C, Lai X, Zhang Y, Xie L, Yu Z, Dan S, Jiang Y, Chen W, Liu L, Yang Y, Huang D, Zhao Y, Zheng J. NADPH metabolism determines the leukemogenic capacity and drug resistance of AML cells. Cell Rep. 2022;39(1):110607. https:\/\/doi.org\/10.1016\/j.celrep.2022.110607.","journal-title":"Cell Rep"},{"key":"4640_CR22","doi-asserted-by":"publisher","first-page":"116913","DOI":"10.1016\/j.bcp.2025.116913","volume":"236","author":"J Zhan","year":"2025","unstructured":"Zhan J, Chen Y, Liu Y, Chen Y, Li Z, Li X, He Z, Meng F, Qian X, Yang L, Yang Q. IDO1-mediated AhR activation up-regulates pentose phosphate pathway via NRF2 to inhibit ferroptosis in lung cancer. Biochem Pharmacol. 2025;236:116913. https:\/\/doi.org\/10.1016\/j.bcp.2025.116913.","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"4640_CR23","doi-asserted-by":"publisher","first-page":"e2408789","DOI":"10.1002\/advs.202408789","volume":"12","author":"J Wang","year":"2025","unstructured":"Wang J, Chen J, Fan K, Wang M, Gao M, Ren Y, Wu S, He Q, Tu K, Xu Q, Zhang Y. Inhibition of Endoplasmic Reticulum Stress Cooperates with SLC7A11 to Promote Disulfidptosis and Suppress Tumor Growth upon Glucose Limitation. Adv Sci (Weinh). 2025;12(7):e2408789. https:\/\/doi.org\/10.1002\/advs.202408789.","journal-title":"Adv Sci (Weinh)"},{"key":"4640_CR24","doi-asserted-by":"publisher","first-page":"123178","DOI":"10.1016\/j.biomaterials.2025.123178","volume":"319","author":"K Wang","year":"2025","unstructured":"Wang K, Li L, Liang G, Xiao H, Zhang L, Liu T. Sonodynamic activated nanoparticles with Glut1 inhibitor and cystine-containing polymer stimulate disulfidptosis for improved immunotherapy in bladder cancer. Biomaterials. 2025;319:123178. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123178.","journal-title":"Biomaterials"},{"key":"4640_CR25","doi-asserted-by":"publisher","first-page":"114895","DOI":"10.1016\/j.addr.2023.114895","volume":"198","author":"P Wen","year":"2023","unstructured":"Wen P, Ke W, Dirisala A, Toh K, Tanaka M, Li J. Stealth and pseudo-stealth nanocarriers. Adv Drug Deliv Rev. 2023;198:114895. https:\/\/doi.org\/10.1016\/j.addr.2023.114895.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"4640_CR26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s12951-022-01605-4","volume":"20","author":"S Waheed","year":"2022","unstructured":"Waheed S, Li Z, Zhang F, Chiarini A, Armato U, Wu J. Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery. J Nanobiotechnol. 2022;20(1):395. https:\/\/doi.org\/10.1186\/s12951-022-01605-4.","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"4640_CR27","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1021\/jacs.0c09029","volume":"143","author":"J Li","year":"2021","unstructured":"Li J, Kataoka K. Chemo-physical Strategies to Advance the in Vivo Functionality of Targeted Nanomedicine: The Next Generation. J Am Chem Soc. 2021;143(2):538\u201359. https:\/\/doi.org\/10.1021\/jacs.0c09029.","journal-title":"J Am Chem Soc"},{"key":"4640_CR28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jconrel.2017.08.027","volume":"264","author":"Z Chai","year":"2017","unstructured":"Chai Z, Hu X, Wei X, Zhan C, Lu L, Jiang K, Su B, Ruan H, Ran D, Fang RH, Zhang L, Lu W. A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery. J Control Release. 2017;264:102\u201311. https:\/\/doi.org\/10.1016\/j.jconrel.2017.08.027.","journal-title":"J Control Release"},{"issue":"3","key":"4640_CR29","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1093\/nsr\/nwz037","volume":"6","author":"M Xuan","year":"2019","unstructured":"Xuan M, Shao J, Li J. Cell membrane-covered nanoparticles as biomaterials. Natl Sci Rev. 2019;6(3):551\u201361. https:\/\/doi.org\/10.1093\/nsr\/nwz037.","journal-title":"Natl Sci Rev"},{"key":"4640_CR30","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez-Borbolla A, Garc\u00eda-Hevia L, Fanarraga ML. Cell Membrane-Coated Nanoparticles for Precision Medicine: A Comprehensive Review of Coating Techniques for Tissue-Specific Therapeutics. Int J Mol Sci. 2024;25(4). https:\/\/doi.org\/10.3390\/ijms25042071.","DOI":"10.3390\/ijms25042071"},{"issue":"20","key":"4640_CR31","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/cmdc.201600276","volume":"11","author":"H Siebeneicher","year":"2016","unstructured":"Siebeneicher H, Cleve A, Rehwinkel H, Neuhaus R, Heisler I, M\u00fcller T, Bauser M, Buchmann B. Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876. ChemMedChem. 2016;11(20):2261\u201371. https:\/\/doi.org\/10.1002\/cmdc.201600276.","journal-title":"ChemMedChem"},{"issue":"1","key":"4640_CR32","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41392-020-00326-0","volume":"5","author":"HQ Ju","year":"2020","unstructured":"Ju HQ, Lin JF, Tian T, Xie D, Xu RH. NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications. Signal Transduct Target Ther. 2020;5(1):231. https:\/\/doi.org\/10.1038\/s41392-020-00326-0.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"4640_CR33","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1158\/1078-0432.Ccr-20-4221","volume":"27","author":"NM Kendsersky","year":"2021","unstructured":"Kendsersky NM, Lindsay J, Kolb EA, Smith MA, Teicher BA, Erickson SW, Earley EJ, Mosse YP, Martinez D, Pogoriler J, Krytska K, Patel K, Groff D, Tsang M, Ghilu S, Wang Y, Seaman S, Feng Y, Croix BS, Gorlick R, Kurmasheva R, Houghton PJ, Maris JM. The B7-H3-Targeting Antibody-Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models. Clin Cancer Res. 2021;27(10):2938\u201346. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-20-4221.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"4640_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10555-025-10294-y","volume":"44","author":"L Jansen","year":"2025","unstructured":"Jansen L, Wienke J, Molkenbur R, Rossig C, Meissner R. B7-H3 in the tumor microenvironment: Implications for CAR T cell therapy in pediatric solid tumors. Cancer Metastasis Rev. 2025;44(4):77. https:\/\/doi.org\/10.1007\/s10555-025-10294-y.","journal-title":"Cancer Metastasis Rev"},{"issue":"15","key":"4640_CR35","doi-asserted-by":"publisher","first-page":"e2106511","DOI":"10.1002\/smll.202106511","volume":"18","author":"W Xu","year":"2022","unstructured":"Xu W, Qing X, Liu S, Yang D, Dong X, Zhang Y. Hollow Mesoporous Manganese Oxides: Application in Cancer Diagnosis and Therapy. Small. 2022;18(15):e2106511. https:\/\/doi.org\/10.1002\/smll.202106511.","journal-title":"Small"},{"key":"4640_CR36","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.actbio.2021.03.048","volume":"126","author":"X Xu","year":"2021","unstructured":"Xu X, Duan J, Liu Y, Kuang Y, Duan J, Liao T, Xu Z, Jiang B, Li C. Multi-stimuli responsive hollow MnO(2)-based drug delivery system for magnetic resonance imaging and combined chemo-chemodynamic cancer therapy. Acta Biomater. 2021;126:445\u201362. https:\/\/doi.org\/10.1016\/j.actbio.2021.03.048.","journal-title":"Acta Biomater"},{"key":"4640_CR37","unstructured":"Ge T, Song Z, Xue Y, Lin C, Lu N, Qu P, Liu M. Anti-B7-H3 antibody and use thereof. Chinese patent CN120209147B. 2025."},{"key":"4640_CR38","doi-asserted-by":"publisher","first-page":"31053","DOI":"10.3402\/jev.v5.31053","volume":"5","author":"SA Kooijmans","year":"2016","unstructured":"Kooijmans SA, Aleza CG, Roffler SR, van Solinge WW, Vader P, Schiffelers RM. Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting. J Extracell Vesicles. 2016;5:31053. https:\/\/doi.org\/10.3402\/jev.v5.31053.","journal-title":"J Extracell Vesicles"},{"issue":"8","key":"4640_CR39","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1158\/1078-0432.Ccr-18-0432","volume":"25","author":"RG Majzner","year":"2019","unstructured":"Majzner RG, Theruvath JL, Nellan A, Heitzeneder S, Cui Y, Mount CW, Rietberg SP, Linde MH, Xu P, Rota C, Sotillo E, Labanieh L, Lee DW, Orentas RJ, Dimitrov DS, Zhu Z, Croix BS, Delaidelli A, Sekunova A, Bonvini E, Mitra SS, Quezado MM, Majeti R, Monje M, Sorensen PHB, Maris JM. Mackall, CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors. Clin Cancer Res. 2019;25(8):2560\u201374. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-0432.","journal-title":"Clin Cancer Res"},{"key":"4640_CR40","doi-asserted-by":"publisher","unstructured":"Al-Hadidi A, Rinehardt HN, Sutthatarn P, Talbot LJ, Murphy AJ, Whitlock R, Condon S, Naik-Mathuria B, Utria AF, Rothstein DH, Chen SY, Wong-Michalak S, Kim ES, Short SS, Meyers RL, Kastenberg ZJ, Johnston ME 2nd, Zens T, Dasgupta R, Malek MM, Calabro K, Pich\u00e9 N, Callas H, Lautz TB, McKay K, Lovvorn HN 3rd, Commander SJ, Tracy ET, Lund SB, Polites SF, Davidson J, Dhooma J, Seemann NM, Marquart JP, Gainer H, Lal DR, Rich BS, Glick RD, Maloney L, Radu S, Fialkowski EA, Kwok PE, Romao RLP, Rubalcava N, Ehrlich PF, Newman E, Diehl T, Le HD, Polcz V, Petroze RT, Stanek J, Aldrink JH. Incidence and management of pleural effusions in patients with Wilms tumor: A Pediatric Surgical Oncology Research Collaborative study. Int J Cancer. 2022;151(10):1696\u2013702. https:\/\/doi.org\/10.1002\/ijc.34188.","DOI":"10.1002\/ijc.34188"},{"issue":"8","key":"4640_CR41","doi-asserted-by":"publisher","first-page":"978","DOI":"10.6004\/jnccn.2021.7070","volume":"19","author":"JS Dome","year":"2021","unstructured":"Dome JS, Mullen EA, Dix DB, Gratias EJ, Ehrlich PF, Daw NC, Geller JI, Chintagumpala M, Khanna G, Kalapurakal JA, Renfro LA, Perlman EJ, Grundy PE, Fernandez CV. Impact of the First Generation of Children\u2019s Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor. J Natl Compr Canc Netw. 2021;19(8):978\u201385. https:\/\/doi.org\/10.6004\/jnccn.2021.7070.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"4640_CR42","doi-asserted-by":"publisher","first-page":"e13752","DOI":"10.1111\/cpr.13752","volume":"58","author":"Y Li","year":"2025","unstructured":"Li Y, Zhang H, Yang F, Zhu D, Chen S, Wang Z, Wei Z, Yang Z, Jia J, Zhang Y, Wang D, Ma M, Kang X. Mechanisms and therapeutic potential of disulphidptosis in cancer. Cell Prolif. 2025;58(1):e13752. https:\/\/doi.org\/10.1111\/cpr.13752.","journal-title":"Cell Prolif"},{"key":"4640_CR43","doi-asserted-by":"publisher","first-page":"102711","DOI":"10.1016\/j.redox.2023.102711","volume":"63","author":"Z Zhong","year":"2023","unstructured":"Zhong Z, Zhang C, Ni S, Ma M, Zhang X, Sang W, Lv T, Qian Z, Yi C, Yu B. NFATc1-mediated expression of SLC7A11 drives sensitivity to TXNRD1 inhibitors in osteoclast precursors. Redox Biol. 2023;63:102711. https:\/\/doi.org\/10.1016\/j.redox.2023.102711.","journal-title":"Redox Biol"},{"issue":"33","key":"4640_CR44","doi-asserted-by":"publisher","first-page":"30303","DOI":"10.1021\/acsnano.5c08432","volume":"19","author":"Y Xu","year":"2025","unstructured":"Xu Y, Ming X, Qi J, Huang Z, Zhu H, Wu M, Feng S, Wan Y. Disulfidptosis Nanoinducer Interrupts Tumor Metabolic Privilege to Boost Sustained Immunotherapy. ACS Nano. 2025;19(33):30303\u201321. https:\/\/doi.org\/10.1021\/acsnano.5c08432.","journal-title":"ACS Nano"},{"issue":"1","key":"4640_CR45","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","volume":"8","author":"D Fan","year":"2023","unstructured":"Fan D, Cao Y, Cao M, Wang Y, Cao Y, Gong T. Nanomedicine in cancer therapy. Signal Transduct Target Ther. 2023;8(1):293. https:\/\/doi.org\/10.1038\/s41392-023-01536-y.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"4640_CR46","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.tibtech.2014.06.010","volume":"32","author":"S Hauert","year":"2014","unstructured":"Hauert S, Bhatia SN. Mechanisms of cooperation in cancer nanomedicine: towards systems nanotechnology. Trends Biotechnol. 2014;32(9):448\u201355. https:\/\/doi.org\/10.1016\/j.tibtech.2014.06.010.","journal-title":"Trends Biotechnol"},{"issue":"1","key":"4640_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01668-1","volume":"9","author":"X Li","year":"2024","unstructured":"Li X, Peng X, Zoulikha M, Boafo GF, Magar KT, Ju Y, He W. Multifunctional nanoparticle-mediated combining therapy for human diseases. Signal Transduct Target Ther. 2024;9(1):1. https:\/\/doi.org\/10.1038\/s41392-023-01668-1.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"4640_CR48","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1021\/acsnano.4c09525","volume":"19","author":"MR Chiang","year":"2025","unstructured":"Chiang MR, Hsu CW, Pan WC, Tran NT, Lee YS, Chiang WH, Liu YC, Chen YW, Chiou SH, Hu SH. Reprogramming Dysfunctional Dendritic Cells by a Versatile Catalytic Dual Oxide Antigen-Captured Nanosponge for Remotely Enhancing Lung Metastasis Immunotherapy. ACS Nano. 2025;19(2):2117\u201335. https:\/\/doi.org\/10.1021\/acsnano.4c09525.","journal-title":"ACS Nano"},{"issue":"27","key":"4640_CR49","doi-asserted-by":"publisher","first-page":"25134","DOI":"10.1021\/acsnano.5c05395","volume":"19","author":"TMH Huynh","year":"2025","unstructured":"Huynh TMH, Huang PX, Wang KL, Tran NT, Iao HM, Pan WC, Chang YH, Lien HW, Lee AY, Chou TC, Chiang WH, Hu SH. Reprogramming Immunodeficiency in Lung Metastases via PD-L1 siRNA Delivery and Antigen Capture of Nanosponge-Mediated Dendritic Cell Modulation. ACS Nano. 2025;19(27):25134\u201353. https:\/\/doi.org\/10.1021\/acsnano.5c05395.","journal-title":"ACS Nano"},{"issue":"6","key":"4640_CR50","doi-asserted-by":"publisher","first-page":"e02817","DOI":"10.1002\/adhm.202502817","volume":"15","author":"HW Lien","year":"2026","unstructured":"Lien HW, Kuo YY, Chang YH, Huynh TMH, Yalamandala BN, Li TC, Iao HM, Pan WC, Lee AY, Chiang WH, Hu SH. Electromagnetic Wireless Remote Control of Reprogramming Immune Dysfunction via N-Doped Carbon Dots-Mesoporous Silica-Mediated Cuproptosis and Dendritic Cell Retention. Adv Healthc Mater. 2026;15(6):e02817. https:\/\/doi.org\/10.1002\/adhm.202502817.","journal-title":"Adv Healthc Mater"},{"issue":"24","key":"4640_CR51","doi-asserted-by":"publisher","first-page":"e23478","DOI":"10.1002\/adfm.202523478","volume":"36","author":"TMH Huynh","year":"2026","unstructured":"Huynh TMH, Tran N-T, Lee Y-S, Chang Y-H, Iao HM, Pan W-C, Lien H-W, Chou T-C, Chiang W-H, Li S-J, Chen Y-Y. Hu, Dysfunctional T Cell Reprogramming via Cascade-Responsive Catalytic Nanosponges-Mediated Tumor-Specific Antigen Capture for Remote Glioblastoma Immunotherapy. Adv Funct Mater. 2026;36(24):e23478. https:\/\/doi.org\/10.1002\/adfm.202523478.","journal-title":"Adv Funct Mater"},{"key":"4640_CR52","doi-asserted-by":"publisher","first-page":"1343929","DOI":"10.3389\/fimmu.2024.1343929","volume":"15","author":"MS Lutz","year":"2024","unstructured":"Lutz MS, Wang K, Jung G, Salih HR, Hagelstein I. An Fc-modified monoclonal antibody as novel treatment option for pancreatic cancer. Front Immunol. 2024;15:1343929. https:\/\/doi.org\/10.3389\/fimmu.2024.1343929.","journal-title":"Front Immunol"},{"issue":"1","key":"4640_CR53","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-023-01751-9","volume":"22","author":"AA Getu","year":"2023","unstructured":"Getu AA, Tigabu A, Zhou M, Lu J, Fodstad \u00d8, Tan M. New frontiers in immune checkpoint B7-H3 (CD276) research and drug development. Mol Cancer. 2023;22(1):43. https:\/\/doi.org\/10.1186\/s12943-023-01751-9.","journal-title":"Mol Cancer"},{"issue":"1","key":"4640_CR54","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41467-017-01050-0","volume":"8","author":"G Yang","year":"2017","unstructured":"Yang G, Xu L, Chao Y, Xu J, Sun X, Wu Y, Peng R, Liu Z. Hollow MnO(2) as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses. Nat Commun. 2017;8(1):902. https:\/\/doi.org\/10.1038\/s41467-017-01050-0.","journal-title":"Nat Commun"},{"issue":"4","key":"4640_CR55","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1021\/nn405773r","volume":"8","author":"P Prasad","year":"2014","unstructured":"Prasad P, Gordijo CR, Abbasi AZ, Maeda A, Ip A, Rauth AM, DaCosta RS, Wu XY. Multifunctional albumin-MnO\u2082 nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response. ACS Nano. 2014;8(4):3202\u201312. https:\/\/doi.org\/10.1021\/nn405773r.","journal-title":"ACS Nano"},{"issue":"1","key":"4640_CR56","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12951-021-00901-9","volume":"19","author":"ZH Zhou","year":"2021","unstructured":"Zhou ZH, Liang SY, Zhao TC, Chen XZ, Cao XK, Qi M, Huang YY, Ju WT, Yang M, Zhu DW, Pang YC, Zhong LP. Overcoming chemotherapy resistance using pH-sensitive hollow MnO(2) nanoshells that target the hypoxic tumor microenvironment of metastasized oral squamous cell carcinoma. J Nanobiotechnol. 2021;19(1):157. https:\/\/doi.org\/10.1186\/s12951-021-00901-9.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"4640_CR57","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","volume":"18","author":"X Jing","year":"2019","unstructured":"Jing X, Yang F, Shao C, Wei K, Xie M, Shen H, Shu Y. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;18(1):157. https:\/\/doi.org\/10.1186\/s12943-019-1089-9.","journal-title":"Mol Cancer"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04640-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04640-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04640-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:32:27Z","timestamp":1789079547000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04640-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4640"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04640-7","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study involving human specimens was conducted in accordance with the ethical standards of the Ethics Committee of the Children\u2019s Hospital of Chongqing Medical University and was approved by the Institutional Review Board of the Children\u2019s Hospital of Chongqing Medical University (Approval No. (2022) Ethics Review (Research) No. 170). Written informed consent was obtained from the legal guardians of all participants. All animal procedures were approved by the Animal Ethics Committee of the Children\u2019s Hospital of Chongqing Medical University (Approval No. CHCMU-IACUC20220323001) and were conducted in accordance with relevant institutional guidelines for animal care and use.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors contributed significantly to the conception, design, execution, and interpretation of the research. They reviewed and approved the manuscript and agreed to be listed as co-authors.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"854"}}